MCM
CVS icon

MidAtlantic Capital Management’s CVS Health CVS Stock Holding History

MidAtlantic Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-437
Closed -$34.7K – 112
2025
Q4 		$34.7K Buy
+437
New +$34.5K 0.02% 165
2025
Q1 		– Sell
-827
Closed -$37.1K – 111
2024
Q4 		$37.1K Buy
827
+437
+112% +$24.5K 0.03% 149
2024
Q3 		$24.5K Hold
390
– – 0.02% 165
2024
Q2 		$23K Sell
390
-390
-50% -$24.4K 0.02% 159
2024
Q1 		$62.2K Hold
780
– – 0.05% 121
2023
Q4 		$61.6K Buy
+780
New +$55.5K 0.06% 115

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MidAtlantic Capital Management's CVS Position: Q1 2026 in Review

MidAtlantic Capital Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 437 shares — an estimated $34.7K sold.

MidAtlantic Capital Management first reported a position in CVS in Q4 2023 and held it in 6 quarters. The position peaked at $62.2K in Q1 2024. 1,880 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • MidAtlantic Capital Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • MidAtlantic Capital Management sold 437 CVS Health shares in Q1 2026, an estimated $34.7K.
  • MidAtlantic Capital Management first reported a position in CVS Health in Q4 2023 and held it in 6 quarters.
  • MidAtlantic Capital Management's CVS Health position peaked at $62.2K in Q1 2024.
  • 1,880 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on MidAtlantic Capital Management's 13F filing for Q1 2026, filed 8 May 2026.